Biopharm
Hangzhou, China · gmaxbiopharm.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Gmax Biopharm is a clinical-stage biopharmaceutical company focused on GPCR therapeutic antibodies and M-Body development. It works on programs for cardiovascular diseases, metabolic disorders, and cancer, with operations in China and offices in the United States, Australia, and Europe.
They take quote requests by email.
What they offer
GPCR MAb discovery platform
Develops monoclonal antibodies against GPCR targets using a proprietary platform for generation, screening, and development.
Monoclonal antibody development platform
Supports antibody screening, humanization, and engineering to produce candidates with drugability and developability.
M-Body platform
Designs multi-pathway molecules composed of a core antibody and a biologically functional motif for long-acting therapeutic development.
Clinical development programs
Advances therapeutic antibody programs through clinical development.
Preclinical development
Develops antibody programs in preclinical studies.
What they work on
- Modalities
- Small molecule, Antibody, Peptide, Recombinant protein
- Species and models
- animal models
- Assays and studies
- functional assays, screening assays
- Therapeutic areas
- cardiovascular diseases, metabolic disorders, cancer, diabetes, obesity, NASH, pulmonary arterial hypertension, heart failure, solid tumors
- Sites
- Hangzhou, China · Zhengzhou, China · Thousand Oaks, USA · Sydney, Australia · Louvain-la-Neuve, Belgium
- Serves
- China, USA, Australia, Europe
- Address
- 288 Qiuyi Road Binjiang District, Hangzhou, China 310052
- Founded
- 2010
Public records
Similar labs. Anthem, Aptamer Group, Aurigene Pharmaceutical Services, Avenue Biosciences
Found in a contract services directory. Listing built from gmaxbiopharm.com. Work here? Claim this listing.